Wize Pharma merges with Australian Bitcoin miner Cosmos
The Israeli biopharmaceutical company will spin off its drug development activity and focus on Bitcoin mining.
Israeli clinical stage biopharmaceutical company Wize Pharma Inc. (OTCQB: WIZP) will merge with privately-held Australian digital currency infrastructure provider Cosmos Capital, in an all share deal, which will ultimately leave Cosmos s shareholders owning most of Wize s shares. Wize, which is controlled by Rimon Gold, the investment arm of serial entrepreneur Yair Goldfinger, US investor Jonathan Rubini, and its CEO Noam Danenberg, will spin off its ophthalmic disorders drug development activities.
Cosmos, which was founded 18 months ago, mainly specializes in mining Bitcoin as well as providing a digital infrastructure, which aims to act as a bridge between the growing digital currency industry and traditional capital markets. Mining Bitcoin is a process of verifying transactions in digital currencies through the